InsidersTradesSigma
Total declarations
Company
▲ Purchases (11 ops.)
▼ Sales (2 ops.)
Insider track record
OtherDisclosed buys
11
Disclosed sells
2
T+90 hit rate
67%
T+90 mean return
+7.0%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Thermopylae Holdings Ltd.. Director active across 1 company, notably AbCellera Biologics Inc.. In total, 16 reports have been recorded. Split: 11 buys · 2 sells. Total volume traded: €243.1m. Activity tracked since 9 June 2021. The latest transaction was filed on 11 March 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations16 total
343,631 shares@ US$2.160.3% of flowCommon SharesSEC:0001628280-25-012154:0
Ideal exit: 6 Dec 2025 (T+270)
286,000 shares0Common SharesSEC:0001628280-24-050097:0
283,516 shares@ US$2.610.3% of flowCommon SharesSEC:0001628280-24-038829:0
Ideal exit: 26 May 2025 (T+270)
210,000 shares0Common SharesSEC:0001703057-23-000049:0
153,000 shares@ US$6.52110.4% of flowCommon SharesSEC:0001209191-23-032481:0
Ideal exit: 20 Feb 2024 (T+270)
85,102 shares@ US$10.09670.3% of flowCommon SharesSEC:0001209191-22-062090:0
Ideal exit: 12 Sept 2023 (T+270)
70,000 shares0Common SharesSEC:0001209191-22-056271:0
200,000 shares@ US$11.46230.9% of flowCommon SharesSEC:0001209191-22-046998:0
Ideal exit: 16 May 2023 (T+270)
54,915 shares@ US$8.03180.034% mcap0.2% of flowCommon SharesSEC:0001209191-22-036884:0
Ideal exit: 10 Mar 2023 (T+270)
64,545 shares@ US$7.49810.036% mcap0.2% of flowCommon SharesSEC:0001209191-22-034983:0
Ideal exit: 3 Mar 2023 (T+270)
300,000 shares@ US$7.25510.17% mcap0.9% of flowCommon SharesSEC:0001209191-22-029541:0
Ideal exit: 7 Feb 2023 (T+270)
1,408,468 shares@ US$6.40540.70% mcap3.7% of flowCommon SharesSEC:0001209191-22-029092:0
Ideal exit: 6 Feb 2023 (T+270)
202,960 shares@ US$14.76110.21% mcap1.1% of flowCommon SharesSEC:0001209191-21-064377:0
Ideal exit: 8 Aug 2022 (T+270)
202,960 shares@ US$14.76111.1% of flowCommon SharesSEC:0001209191-21-064377
Ideal exit: 8 Aug 2022 (T+270)
5,598,420 shares@ US$24.038.84% mcap46.4% of flowCommon SharesSEC:0000899243-21-022994:0
5,598,420 shares@ US$24.0345.4% of flowCommon SharesSEC:0000899243-21-022994
16 of 16 declarations
About Thermopylae Holdings Ltd.
Thermopylae Holdings Ltd. is a director and insider at AbCellera Biologics Inc.
